Why I'm telling friends to avoid gold stocks

Back in November, gold made a tiny move of 1.6%. But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period. It's all about catching what I call "Acceleration Cycles."

And if you’d like to get your hands on this, here you go, the complete breakdown.

BCEL Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Notice: This stock is marked as potentially delisted. It may not be actively trading.

Insider Ownership Percentage: 11.30%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

Atreca Insider Trading History Chart

Atreca Share Price & Price History

^$0.09

+0.30 (1.20%)

As of 09/25/2024 01:00 AM ET

After New Years, price goes back up 4,800%

From StocksToTrade | Ad

When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds for a dollar anymore!

Click here to review Tim’s special Holiday offer before it’s too late.

Atreca Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/19/2023	Bros. Advisors Lp Baker	Major Shareholder	Sell	274,739	$0.40	$109,895.60	286,893
8/2/2023	Phillips Courtney	General Counsel	Sell	4,076	$0.95	$3,872.20	57,492
8/2/2023	Tito Serafini	Insider	Sell	5,487	$0.95	$5,212.65	72,817
9/2/2022	John A Orwin	CEO	Sell	20,908	$1.78	$37,216.24	100,492
9/2/2022	Phillips Courtney	General Counsel	Sell	6,432	$1.78	$11,448.96	29,068
9/2/2022	Tito Serafini	Insider	Sell	7,646	$1.78	$13,609.88	34,554
6/28/2022	Tito Serafini	Insider	Sell	15,000	$2.02	$30,300.00	228,875
3/4/2022	Tito Serafini	Insider	Sell	30,000	$5.00	$150,000.00

How Low-Cost Stocks Generate Monthly Income

From Darwin | Ad

Are you ready to transform your investment strategy and generate a steady monthly income? We’re excited to offer you our exclusive report, "Options Trading Strategy: 2 (Surprisingly) Low-Cost Stocks Primed for Generating Monthly Income," FREE!

👉 Yes, I Want the Free Report! 👈

SEC Filings (Institutional Ownership Changes) for Atreca (NASDAQ:BCEL)

37.47% of Atreca stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Atreca Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/15/2023	Laurion Capital Management LP	142,824	$37K	0.0%	-66.7%	0.363%
8/15/2023	Bill & Melinda Gates Foundation	931,815	$0.91M	0.7%	-7.4%	2.380%
8/11/2023	ExodusPoint Capital Management LP	466,828	$0.46M	0.0%	-8.4%	1.192%
8/7/2023	Acadian Asset Management LLC	44,110	$42K	0.0%	-33.0%	0.113%
8/4/2023	CM Management LLC	350,000	$0.34M	0.3%	+27.3%	0.894%
5/11/2023	ExodusPoint Capital Management LP	509,886	$0.58M	0.0%	+356.2%	1.302%
2/9/2023	CM Management LLC	275,000	$0.22M	0.3%	+10.3%	0.704%
11/15/2022	Bill & Melinda Gates Foundation	1,320,880	$2.10M	1.7%	-0.8%	3.498%
11/10/2022	Connor Clark & Lunn Investment Management Ltd.	97,264	$0.15M	0.0%	+79.1%	0.258%
11/4/2022	CM Management LLC	249,282	$0.39M	0.4%	+10.8%	0.660%
8/15/2022	Laurion Capital Management LP	492,200	$0.88M	0.0%	N/A	1.304%
8/8/2022	CM Management LLC	225,000	$0.40M	0.4%	+50.0%	0.596%
8/5/2022	Connor Clark & Lunn Investment Management Ltd.	54,301	$97K	0.0%	-33.6%	0.144%
7/14/2022	Gofen & Glossberg LLC IL	25,000	$45K	0.0%	+66.7%	0.066%
5/12/2022	Connor Clark & Lunn Investment Management Ltd.	81,751	$0.26M	0.0%	N/A	0.217%
5/9/2022	CM Management LLC	150,000	$0.48M	0.4%	+130.8%	0.397%
4/29/2022	McDonald Partners LLC	13,200	$42K	0.0%	N/A	0.035%
4/14/2022	Gofen & Glossberg LLC IL	15,000	$48K	0.0%	N/A	0.040%
3/3/2022	Walleye Capital LLC	274,540	$0.83M	0.0%	+2,130.9%	0.739%
2/14/2022	PDT Partners LLC	95,926	$0.29M	0.0%	+16.1%	0.258%
2/14/2022	Redmile Group LLC	800,306	$2.43M	0.1%	-31.6%	2.154%
2/14/2022	Hound Partners LLC	982,386	$2.98M	0.2%	N/A	2.644%
2/9/2022	BNP Paribas Arbitrage SA	40,194	$0.12M	0.0%	+675.0%	0.108%
2/8/2022	Northern Trust Corp	249,074	$0.76M	0.0%	-3.4%	0.670%
2/7/2022	SG Americas Securities LLC	10,624	$32K	0.0%	-59.2%	0.029%
2/2/2022	CM Management LLC	65,000	$0.20M	0.1%	-18.8%	0.175%
1/20/2022	Parallel Advisors LLC	8,114	$25K	0.0%	-50.4%	0.022%
12/14/2021	UBS Asset Management Americas Inc.	67,312	$0.42M	0.0%	+37.7%	0.181%
11/16/2021	Schonfeld Strategic Advisors LLC	10,500	$65K	0.0%	N/A	0.028%
11/16/2021	Corient Capital Partners LLC	71,325	$0.44M	0.0%	N/A	0.193%
11/16/2021	Squarepoint Ops LLC	12,832	$80K	0.0%	-79.7%	0.035%
11/16/2021	Wellington Management Group LLP	1,934,255	$12.05M	0.0%	-21.1%	5.243%
11/16/2021	Millennium Management LLC	431,517	$2.69M	0.0%	-5.1%	1.170%
11/15/2021	Dynamic Technology Lab Private Ltd	15,415	$96K	0.0%	N/A	0.042%
11/15/2021	Franklin Resources Inc.	13,534	$84K	0.0%	N/A	0.037%
11/12/2021	Trexquant Investment LP	25,818	$0.16M	0.0%	-43.6%	0.070%
11/12/2021	Renaissance Technologies LLC	133,706	$0.83M	0.0%	+22.7%	0.362%
11/12/2021	Jump Financial LLC	14,800	$92K	0.0%	N/A	0.040%
11/12/2021	Geode Capital Management LLC	534,745	$3.33M	0.0%	+19.0%	1.449%
11/10/2021	Goldman Sachs Group Inc.	69,190	$0.43M	0.0%	-30.7%	0.188%
11/10/2021	Citigroup Inc.	5,466	$34K	0.0%	-48.2%	0.015%
11/9/2021	Barclays PLC	32,255	$0.20M	0.0%	+169.2%	0.087%
11/9/2021	BlackRock Inc.	2,960,456	$18.44M	0.0%	+3.0%	8.025%
11/9/2021	Platinum Investment Management Ltd.	398,541	$2.48M	0.1%	+25.7%	1.080%
11/8/2021	CM Management LLC	80,000	$0.50M	0.4%	+33.3%	0.217%
11/4/2021	Deutsche Bank AG	45,759	$0.29M	0.0%	+196.5%	0.124%
11/1/2021	SG Americas Securities LLC	26,019	$0.16M	0.0%	N/A	0.071%
10/21/2021	Virginia Retirement Systems ET AL	22,400	$0.14M	0.0%	N/A	0.061%
10/19/2021	Vigilare Wealth Management	18,950	$0.12M	0.1%	-42.8%	0.051%
9/17/2021	Virtu Financial LLC	23,009	$0.20M	0.0%	N/A	0.062%
9/3/2021	Parametric Portfolio Associates LLC	36,016	$0.31M	0.0%	+47.2%	0.098%
8/25/2021	Marshall Wace LLP	34,465	$0.29M	0.0%	N/A	0.093%
8/18/2021	Ikarian Capital LLC	250,000	$2.13M	0.2%	N/A	0.678%
8/17/2021	Millennium Management LLC	454,563	$3.87M	0.0%	+77.4%	1.232%
8/17/2021	Boothbay Fund Management LLC	37,163	$0.32M	0.0%	N/A	0.101%
8/17/2021	Caas Capital Management LP	42,945	$0.37M	0.0%	N/A	0.116%
8/16/2021	Squarepoint Ops LLC	63,184	$0.54M	0.0%	+113.5%	0.171%
8/16/2021	UBS Asset Management Americas Inc.	48,894	$0.42M	0.0%	-84.1%	0.133%
8/16/2021	PDT Partners LLC	54,200	$0.46M	0.0%	+50.4%	0.147%
8/16/2021	Cubist Systematic Strategies LLC	74,688	$0.64M	0.0%	N/A	0.202%
8/16/2021	Redmile Group LLC	2,460,268	$20.96M	0.3%	-1.2%	6.668%
8/16/2021	California State Teachers Retirement System	35,777	$0.31M	0.0%	-17.9%	0.097%
8/16/2021	Charles Schwab Investment Management Inc.	66,197	$0.56M	0.0%	-9.3%	0.179%
8/16/2021	State Street Corp	491,632	$4.19M	0.0%	-56.4%	1.333%
8/16/2021	Federated Hermes Inc.	198,570	$1.69M	0.0%	N/A	0.538%
8/16/2021	Goldman Sachs Group Inc.	99,913	$0.85M	0.0%	-63.0%	0.271%
8/16/2021	Macquarie Group Ltd.	6,366	$54K	0.0%	+730.0%	0.017%
8/16/2021	Marshall Wace LLP	34,465	$0.29M	0.0%	N/A	0.093%
8/13/2021	Renaissance Technologies LLC	108,980	$0.93M	0.0%	N/A	0.295%
8/13/2021	Northern Trust Corp	269,255	$2.29M	0.0%	-17.2%	0.730%
8/13/2021	Algert Global LLC	18,320	$0.16M	0.1%	-41.8%	0.050%
8/13/2021	Stifel Financial Corp	32,563	$0.28M	0.0%	+27.5%	0.088%
8/13/2021	Ensign Peak Advisors Inc	628,536	$5.36M	0.0%	+1.6%	1.704%
8/13/2021	Geode Capital Management LLC	449,553	$3.83M	0.0%	-1.2%	1.218%
8/13/2021	Vanguard Group Inc.	1,352,108	$11.52M	0.0%	-9.1%	3.665%
8/12/2021	Trexquant Investment LP	45,782	$0.39M	0.0%	N/A	0.124%
8/12/2021	Dimensional Fund Advisors LP	64,208	$0.55M	0.0%	-46.4%	0.174%
8/12/2021	JPMorgan Chase & Co.	73,493	$0.63M	0.0%	+344.3%	0.199%
8/12/2021	Ergoteles LLC	21,500	$0.18M	0.0%	N/A	0.058%
8/11/2021	Bank of New York Mellon Corp	90,241	$0.77M	0.0%	-15.2%	0.245%
8/11/2021	BlackRock Inc.	2,875,550	$24.50M	0.0%	+19.1%	7.794%
8/11/2021	Deutsche Bank AG	15,435	$0.13M	0.0%	-20.5%	0.042%
8/10/2021	Virtus ETF Advisers LLC	21,550	$0.18M	0.1%	+20.7%	0.058%
8/10/2021	Citigroup Inc.	10,561	$90K	0.0%	-81.7%	0.029%
8/6/2021	Swiss National Bank	53,200	$0.45M	0.0%	-13.8%	0.144%
8/5/2021	Rhumbline Advisers	34,125	$0.29M	0.0%	+22.2%	0.093%
8/5/2021	Los Angeles Capital Management LLC	40,339	$0.34M	0.0%	+43.8%	0.109%
8/2/2021	New York State Common Retirement Fund	12,843	$0.11M	0.0%	-46.7%	0.035%
7/31/2021	Vigilare Wealth Management	33,150	$0.28M	0.2%	+50.3%	0.090%
7/30/2021	Alliancebernstein L.P.	27,100	$0.23M	0.0%	+29.7%	0.073%
5/19/2021	Copernicus Capital Management LLC	18,000	$0.28M	4.5%	N/A	0.049%
5/19/2021	Squarepoint Ops LLC	29,590	$0.45M	0.0%	+34.8%	0.080%
5/18/2021	Morgan Stanley	164,834	$2.53M	0.0%	-19.1%	0.448%
5/18/2021	Redmile Group LLC	2,490,568	$38.18M	0.5%	+0.6%	6.762%
5/18/2021	Samsara BioCapital LLC	396,835	$6.08M	1.1%	-16.4%	1.077%
5/17/2021	PDT Partners LLC	36,031	$0.55M	0.0%	N/A	0.098%
5/17/2021	Royal Bank of Canada	2,309	$36K	0.0%	+438.2%	0.006%
5/17/2021	Rock Springs Capital Management LP	453,930	$6.96M	0.2%	+0.6%	1.232%
5/17/2021	HRT Financial LP	13,748	$0.21M	0.0%	N/A	0.037%
5/17/2021	Nuveen Asset Management LLC	116,198	$1.78M	0.0%	+7.4%	0.315%

Data available starting January 2016

Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-101 product candidate reacts in vitro with a majority of human ovarian, non-small cell lung, colorectal, and breast cancer samples from multiple patients; and ATRC-501/MAM01, that targets the circumsporozoite protein of Plasmodium falciparum for the treatment of malaria. Its products in pre-clinical stage include APN-497444, an antibody drug conjugate (ADC) against a novel tumor glycan target; and APN-346958, a CD3 bispecific T-cell engager against an RNA-binding protein target. It has a collaboration and license agreement with Xencor, Inc. for research, development, and commercialization of novel CD3 bispecific antibodies in oncology; licensing agreement with the Bill & Melinda Gates Medical Research Institute for the development and commercialization of MAM01/ATRC-501 for the prevention of malaria. The company was incorporated in 2010 and is based in San Carlos, California.

Today's Range

Now: $0.09

$0.09

50 Day Range

MA: $0.09

$0.09

52 Week Range

Now: $0.09

$0.05

$1.20

Volume

N/A

Average Volume

4,609,200 shs

Market Capitalization

$3.57 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.03

Who are the company insiders with the largest holdings of Atreca?: Atreca's top insider shareholders include:
Bros Advisors Lp Baker (Major Shareholder)
Tito Serafini (Insider)
Phillips Courtney (General Counsel)
Learn More about top insider investors at Atreca.